Proprotein convertase subtilisin/kexin type 9 inhibitors on the horns of a dilemma: which lipoprotein we should primarily target – low-density lipoprotein or lipoprotein(a)?

Second Department of Cardiology, Athens Naval Hospital, Athens, Greece

Correspondence to Andreas S. Papazoglou, MD, Second Department of Cardiology, Naval Hospital of Athens: Nautiko Nosokomeio Athenon, Athens, Greece. E-mail: [email protected]

Received 17 March, 2022